According to Technavio, the Global Precision Medicine Market is poised for substantial growth, with an estimated increase of USD 66.2 billion from 2023 to 2028, representing a CAGR of 12.34%. The demand for personalized healthcare, particularly for managing chronic diseases like cancer and cardiovascular disorders, is driving this expansion. Precision medicine tailors treatments based on an individual's unique genetic makeup, offering higher efficacy and fewer side effects. Technological advancements in genomics and proteomics are playing a critical role in enhancing diagnostics and treatment strategies. Oncology, in particular, is benefiting from these advancements as targeted cancer therapies become more prevalent. North America is expected to lead the market due to its advanced healthcare infrastructure and strong focus on R&D. However, concerns surrounding data privacy and high treatment costs remain challenges for broader adoption. Despite these hurdles, the market's future looks promising as new therapies and technologies continue to emerge.

Click here to download Precision Medicine Market Sample PDF Click here to Contact us for more Information